Heparin does not seem to improve the function of pulmonary grafts for lung transplantation

References

• Dilling DF, Glanville AR. Advances in lung transplantation: the year in review. J Heart Lung Transplant. 2011;30: 247–51.
   PubMed Web of Science ®Google Scholar
• Knudsen L, Boxler L, Muhlfeld C, Schaefer IM, Becker L, Bussinger C, et al. Lung preservation in experimental ischemia/reperfusion injury and lung transplantation: a comparison of natural and synthetic surfactants. J Heart Lung Transplant. 2012;31:85–93.
   PubMed Web of Science ®Google Scholar
• Dominguez-Gil B, Haase-Kromwijk B, Van Leiden H, Neuberger J, Coene L, Morel P, et al. Current situation of donation after circulatory death in European countries. Transpl Int. 2011;24:676–86.
   PubMed Web of Science ®Google Scholar
• Egan TM, Lambert CJ Jr, Reddick R, Ulicny KS Jr, Keagy BA, Wilcox BR. A strategy to increase the donor pool: use of cadaver lungs for transplantation. Ann Thorac Surg. 1991;52:1113–20; discussion 20–1.
   PubMed Web of Science ®Google Scholar
• Cypel M, Yeung JC, Keshavjee S. Novel approaches to expanding the lung donor pool: donation after cardiac death and ex vivo conditioning. Clin Chest Med. 2011;32:233–44.
   PubMed Web of Science ®Google Scholar
• Bolys R, Ingemansson R, Sjoberg T, Steen S. Vascular function in the cadaver up to six hours after cardiac arrest. J Heart Lung Transplant. 1999;18:582–6.
   PubMed Web of Science ®Google Scholar
• De Vleeschauwer S, Van Raemdonck D, Vanaudenaerde B, Vos R, Meers C, Wauters S, et al. Early outcome after lung transplantation from non-heart-beating donors is comparable to heart-beating donors. J Heart Lung Transplant. 2009;28:380–7.
   PubMed Web of Science ®Google Scholar
• Kootstra G, Daemen JH, Oomen AP. Categories of non-heart-beating donors. Transplant Proc. 1995;27:2893–4.
   PubMed Web of Science ®Google Scholar
• Pizanis N, Petrov A, Heckmann J, Wiswedel I, Wohlschlager J, de Groot H, et al. A new preservation solution for lung transplantation: evaluation in a porcine transplantation model. J Heart Lung Transplant. 2012;31:310–7.
   PubMed Web of Science ®Google Scholar
• Ingemansson R, Massa G, Pandita RK, Sjoberg T, Steen S. Perfadex is superior to Euro-Collins solution regarding 24-hour preservation of vascular function. Ann Thorac Surg. 1995;60:1210–4.
   PubMed Web of Science ®Google Scholar
• Steen S, Kimblad PO, Sjoberg T, Lindberg L, Ingemansson R, Massa G. Safe lung preservation for twenty-four hours with Perfadex. Ann Thorac Surg. 1994;57:450–7.
   PubMed Web of Science ®Google Scholar
• Marasco SF, Bailey M, McGlade D, Snell G, Westall G, Oto T, Pilcher D. Effect of donor preservation solution and survival in lung transplantation. J Heart Lung Transplant. 2011;30:414–9.
   PubMed Web of Science ®Google Scholar
• Ohsumi A, Chen F, Sakamoto J, Nakajima D, Hijiya K, Motoyama H, et al. Protective effect of pre-recovery surfactant inhalation on lungs donated after cardiac death in a canine lung transplantation model. J Heart Lung Transplant. 2012;31:1136–42.
   PubMed Web of Science ®Google Scholar
• Motta ED. The ethics of heparin administration to the potential non-heart-beating organ donor. J Prof Nurs. 2005; 21:97–102.
   PubMed Web of Science ®Google Scholar
• Bai X, Fischer S, Keshavjee S, Liu M. Heparin interference with reverse transcriptase polymerase chain reaction of RNA extracted from lungs after ischemia-reperfusion. Transpl Int. 2000;13:146–50.
   PubMed Web of Science ®Google Scholar
• Erasmus ME, Verschuuren EA, Nijkamp DM, Vermeyden JW, van der Bij W. Lung transplantation from nonheparinized category III non-heart-beating donors. A single-centre report. Transplantation. 2010;89:452–7.
   PubMed Web of Science ®Google Scholar
• Wallinder A, Steen S, Liden H, Hansson C, Hussein AA, Sjoberg T, Dellgren G. Heparin does not improve graft function in uncontrolled non-heart-beating lung donation: an experimental study in pigs. Eur J Cardiothorac Surg. 2013;43: 413–9.
   PubMed Web of Science ®Google Scholar
• Sanchez PG, Bittle GJ, Williams K, Pasrija C, Xu K, Wei X, et al. Ex vivo lung evaluation of prearrest heparinization in donation after cardiac death. Ann Surg. 2013;257:534–41.
   PubMed Web of Science ®Google Scholar
• Ingemansson R, Eyjolfsson A, Mared L, Pierre L, Algotsson L, Ekmehag B, et al. Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo. Ann Thorac Surg. 2009;87:255–60.
   PubMed Web of Science ®Google Scholar
• Lindstedt S, Eyjolfsson A, Koul B, Wierup P, Pierre L, Gustafsson R, Ingemansson R. How to recondition ex vivo initially rejected donor lungs for clinical transplantation; clinical experience from Lund University Hospital. J Transpl. 2011;2011:754383.
   PubMedGoogle Scholar
• Steen S, Ingemansson R, Eriksson L, Pierre L, Algotsson L, Wierup P, et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg. 2007;83:2191–4.
   PubMed Web of Science ®Google Scholar
• Cypel M, Yeung JC, Hirayama S, Rubacha M, Fischer S, Anraku M, et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant. 2008;27: 1319–25.
   PubMed Web of Science ®Google Scholar
• Cypel M, Yeung JC, Liu M, Anraku M, Chen F, Karolak W, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med. 2011;364:1431–40.
   PubMed Web of Science ®Google Scholar
• Lindstedt S, Hlebowicz J, Koul B, Wierup P, Sjogren J, Gustafsson R, et al. Comparative outcome of double lung transplantation using conventional donor lungs and non-acceptable donor lungs reconditioned ex vivo. Interact Cardiovasc Thorac Surg. 2010.
   Google Scholar